Shin-Il Kim (김신일)
Executive Director (Dual Employment) @ ViGenCell(바이젠셀)
About
Developing genetically engineered, induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies for cancer immunotherapy and regenerative medicine
South Korea
Seoul
Research
Genome editing in human iPSC, iPSC differentiation to various types of somatic cells including NK cell
Experience

Chief Scientific Officer (Dual Employment)
Seoul, South Korea
http://therabest.co.kr/en/ Therabest is a biopharmaceutical company that develops iPSC-derived immune cells. Our mission is to provide the benefits of cell therapy to many patients. We established a robust process that can manufacture Armored iPSC-CAR-NK, off-the-shelf cell products using our exclusive technology.

R&D Director
Kyoto, Japan
CiRA spin off biotech (http://www.acernatec2.com/cn4/TOP_EN.html) 1. Lead R&D center in developing, communicating, and executing research activities. 2. Product Development and Launching - "RNA Switch series for iPSC-derived target cell purification and elimination" (2019). a. Fujifilm: https://labchem-wako.fujifilm.com/jp/category/01745.html b. Nacalai: https://www.nacalai.co.jp/global/reagent/rna_switch_series.html
Shin-Il Kim (김신일)'s Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.





